Bloomberg BNA Study Analyzes the Impact of Recent Supreme Court Decisions That Leave Life Sciences Industry Under Cloud Of Uncertainty

June 25, 2014

Read the full article (PDF) >

San Diego (June 25, 2014) – Bloomberg BNA and law firm Robins, Kaplan, Miller & Ciresi L.L.P., in conjunction with the Biotechnology Industry Organization, today published a study on the impact of recent U.S. Supreme Court decisions affecting the life sciences industry. The report, Stopped at the Threshold: The Practical Impact of the Supreme Court’s Mayo and Myriad Decisions on Biotechnology Patent Practices, explores the impact of Supreme Court decisions handed down in 2012 and 2013 that have made it more difficult for companies in the multibillion dollar global life sciences industry to obtain patents.

©2014. Used with permission from Bloomberg BNA.

Related Publications

Summer 2020
The Brave New World of Virtual Notarization
Steven Orloff, Manleen Singh - The Robins Kaplan Spotlight, Vol. 5, No. 2
Summer 2020
What Could be the Harm? Minnesota's Harmless Error Statute
Matthew Frerichs, Ena Kovacevic - The Robins Kaplan Spotlight, Vol. 5, No. 2
Summer 2020
What's a Fiduciary To Do? Considerations for Periods of Uncertainty
Anthony Froio, Denise Rahne - The Robins Kaplan Spotlight, Vol. 5, No. 2
June 17, 2020
Big Data in the Wake of Covid-19—A Conundrum for Enforcers
Meegan Hollywood, Adam Mendel - Bloomberg Law
June 2020
Trade Secrets: Safe as Houses
Christopher Larus, David Prange, Alyssa Bixby-Lawson - Intellectual Property Magazine
Back to Top